Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_04799
Species: Homo sapiens
Position : chr1:230294600-230294900
Year: 2016
Title: Looking beyond GWAS: allele-specific transcription factor binding drives the association of GALNT2 to HDL-C plasma levels.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Normal
PMID:  26817450
Tissue: liver
Tissue Ontology ID: UBERON:0002107
Cell Source: Hep-G2
CVCL ID: CVCL_0027
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: GWAS-linked HDL-C regulatory variant; allele-specific enhancer activity and TF binding
High Throughput Method: GWAS; ENCODE/ChIP-seq regulatory-data integration
Low Throughput Method: Dual-luciferase/allele-specific reporter; EMSA; ChIP/ChIP-qPCR; RT-qPCR
About Target Gene
Target gene : GALNT2
About TF
TF name : ZBTB3
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 5 found
Enhancer ID Position Tissue Cell Disease
E_04808 chr1:230293530-230305966 liver hepatocyte NA
E_04796 chr1:230294600-230294900 liver malignant cell NA
E_04797 chr1:230294600-230294900 liver malignant cell NA
E_04798 chr1:230294600-230294900 liver malignant cell NA
E_04807 chr1:230294600-230294900 liver malignant cell NA
Expression of Target Genes for the Enhancer